Adjuvant cisplatin and vinorelbine for completely resected non-small cell lung cancer: subgroup analysis of the Lung Adjuvant Cisplatin Evaluation.
Douillard, Jean-Yves
Adjuvant cisplatin and vinorelbine for completely resected non-small cell lung cancer: subgroup analysis of the Lung Adjuvant Cisplatin Evaluation. [electronic resource] - Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer Feb 2010 - 220-8 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1556-1380
10.1097/JTO.0b013e3181c814e7 doi
Antineoplastic Agents--therapeutic use
Carcinoma, Non-Small-Cell Lung--drug therapy
Chemotherapy, Adjuvant
Chi-Square Distribution
Cisplatin--therapeutic use
Female
Humans
Lung Neoplasms--drug therapy
Male
Meta-Analysis as Topic
Neoplasm Staging
Proportional Hazards Models
Randomized Controlled Trials as Topic
Survival Rate
Treatment Outcome
Vinblastine--analogs & derivatives
Vinorelbine
Adjuvant cisplatin and vinorelbine for completely resected non-small cell lung cancer: subgroup analysis of the Lung Adjuvant Cisplatin Evaluation. [electronic resource] - Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer Feb 2010 - 220-8 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1556-1380
10.1097/JTO.0b013e3181c814e7 doi
Antineoplastic Agents--therapeutic use
Carcinoma, Non-Small-Cell Lung--drug therapy
Chemotherapy, Adjuvant
Chi-Square Distribution
Cisplatin--therapeutic use
Female
Humans
Lung Neoplasms--drug therapy
Male
Meta-Analysis as Topic
Neoplasm Staging
Proportional Hazards Models
Randomized Controlled Trials as Topic
Survival Rate
Treatment Outcome
Vinblastine--analogs & derivatives
Vinorelbine